MedPath
HSA Approval

PROMEDYL-B LINCTUS

SIN02838P

PROMEDYL-B LINCTUS

PROMEDYL-B LINCTUS

May 22, 1989

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

ELIXIR

ORAL

Medical Information

R05DA20

combinations

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

EPHEDRINE HCl

7.2 mg/5 ml

Ephedrine

PROMETHAZINE HCl

3.6 mg/5 ml

Promethazine

CODEINE PHOSPHATE

9 mg/5 ml

Codeine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROMEDYL-B LINCTUS - HSA Approval | MedPath